Skip to main navigation
Skip to search
Skip to main content
WashU Medicine Research Profiles Home
Help & FAQ
Home
Profiles
Departments, Divisions and Centers
Research output
Search by expertise, name or affiliation
Hospitalizations as an outcome measure in COURAGE-ALS
On behalf of the Courage-Als study group
Section of Neuromuscular Medicine
Roy and Diana Vagelos Division of Biology & Biomedical Sciences (DBBS)
DBBS - Biochemistry, Biophysics, and Structural Biology
DBBS - Molecular Cell Biology
DBBS - Neurosciences
Institute of Clinical and Translational Sciences (ICTS)
Center of Regenerative Medicine
Hope Center for Neurological Disorders
Research output
:
Contribution to journal
›
Article
›
peer-review
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Hospitalizations as an outcome measure in COURAGE-ALS'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Hospitalization
100%
Amyotrophic Lateral Sclerosis
100%
Reldesemtiv
29%
Placebo
23%
First Hospitalization
11%
Demographic Characteristics
5%
Hospitalization Risk
5%
Placebo-controlled
5%
Clinical Trials
5%
Bulbar
5%
Clinical Features
5%
Significant Risk Factors
5%
Classification System
5%
Disease Burden
5%
Multivariate Model
5%
Phase II Trial
5%
Number of Hospitalization
5%
Trialists
5%
Clinical Meaningfulness
5%
Biochemistry, Genetics and Molecular Biology
Clinical Trial
100%
Disease Burden
100%
Pharmacology, Toxicology and Pharmaceutical Science
Amyotrophic Lateral Sclerosis
100%
Placebo
29%
Reldesemtiv
29%
Diseases
11%
Clinical Trial
5%
Clinical Feature
5%
Nursing and Health Professions
Amyotrophic Lateral Sclerosis
100%
Placebo
29%
Reldesemtiv
29%
Clinical Feature
5%
Disease Burden
5%
Diseases
5%
Neuroscience
Amyotrophic Lateral Sclerosis
100%
Placebo
31%
Reldesemtiv
31%
Amyotrophic Lateral Sclerosis Clinical Trial
6%
Risk Factor
6%